Related Experiment Video
Updated: Jun 13, 2026

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
Published on: June 8, 2022
[Lipid storage myopathies. A clinical and pathobiochemical challenge]
T Skuban1, T Klopstock, B Schoser
1Friedrich-Baur-Institut, Neurologische Klinik, Klinikum der Universität München, Ziemssenstraße 1a, 80336, München. tobias.skuban@med.uni-muenchen.de
Abstract:
Lipid storage myopathies are a clinically and genetically heterogeneous group of muscle diseases characterized by an accumulation of lipid in skeletal muscle. Currently four different groups of lipid storage myopathies are described: primary carnitine deficiency (PCD), multiple acyl-CoA dehydrogenase deficiency, primary and secondary coenzyme Q10 deficiency and neutral lipid storage diseases. It might be due to their rareness and considerable clinical variability that these disorders are frequently disregarded in neurological differential diagnosis. This article provides a synopsis of several new aspects of pathophysiology, symptoms, diagnostic tools and current therapeutic approaches of lipid storage myopathies.
Related Concept Videos
Lysosomal Hydrolases
Myasthenia Gravis ll: Pathophysiology
Fats as Energy Storage Molecules
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
What are Lipids?
Lipid Catabolism

